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As in all areas of research into schizophrenia, the outstanding feature to date 
of work done on the autonomic nervous system in this condition has been 
the great variability of the findings. Low, normal, and high values of the 
measures used have been reported (Altschule, 1943), and this is true both of 
autonomic activity at rest and of responses to stress and drugs. 
The sample of patients used has 
varied, and often the type of schizophrenic tested or the chronicity of the 
disease has not been recorded. The population used for comparison has often 
consisted of college students, and differences found may be due to the effects of 
hospitalization or a function of age. I n  earlier studies especially, the patients 
have been studied while on drugs, or insufficient time has been allowed to elapse 
between discontinuing medication and starting the tests. Often no measure of 
the patient’s anxiety or emotional reactivity has been made, and differences 
found may have been due to this rather than the disease itself. There have 
been, too, many modifications of instrumentation and of drug dosage in dif- 
ferent studies, with the result that overtly similar studies cannot be reliably 
compared. 
In  testing autonomic activity with drugs, seldom has any attempt been made 
to adjust the dosage on a weight basis, and the route of administration has 
varied even in the same experiment. If drugs are given by the intramuscular 
or subcutaneous route the rate of absorption will vary from patient to patient 
and, even in the same patient, a t  different times. Because of this, the differ- 
ence in the response recorded would not be at  all surprising. 
Our aim has been, therefore, to measure several autonomically controlled 
variables: (1) at rest, (2) during stress, and (3) during response to drugs. 
Much has been written about the various autonomic variables and about what 
they actually measure (Ilarrow, 1943; Lacey, 1956) but we chose those generally 
considered as useful. Although many autonomic drugs have been used they 
fall into various groups: (1) sympathomimetic, (2) parasympathomimetic, ( 3 )  
sympatholytic, and (4) parasympatholytic, and we have used examples from 
each group. 
The possible reasons for this are many. 
Sample 
This study is part of the multidisciplinary investigation into schizophrenia, 
the chief object of which is to test, by applying a wide array of tests to a group 
of schizophrenics of mixed clinical diagnoses, the alternate hypotheses that 
schizophrenia is one disease or that it is many diseases. A further aim of this 
research has been to check tests previously reported as differentiating schizo- 
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phrenics from nonschizophrenics, and we have included, therefore, a control 
group of nonschizophrenics. Because the patients had to meet various criteria 
imposed by the different areas our sample is a specially selected one, but it 
included both acute and chronic patients and examples of the various clinical 
subgroups of schizophrenia. The patients were males, and their ages ranged 
from 18 to 50 with a mean of 35 years. There were 107 schizophrenics, 86 
nonschizophrenics, and 14 of uncertain diagnosis. Before being tested they 
had all been off drugs for two months and, for a month prior to testing, had 
been on a strict diet. 
Method 
Before the stress 
and drug experiments, the patient was familiarized with the procedure and 
with the surroundings of the test room. The environment was kept as con- 
stant as possible, the temperature 25 1" C., humidity 40 per cent, the walls 
of the room were soundproofed, and there was a constant low, level background 
noise from the air conditioner. 
At the end of the first session, recordings of all the measures were taken 
over a 5-min. period, and these were used as baseline values. 
The next session was a stress experiment. After resting in the supine 
position and having had leads applied, a 5-min. baseline was recorded. The 
patient was then given a painful electric shock to his leg preceded a t  a 10-sec. 
interval by a tone every half minute for 5 min., and this was followed by a 
tone only every half minute for 5 min. A 15-min. recovery recording was then 
made. 
The drugs were given over four sessions: (1) yohimbine hydrochloride, (2) 
piperoxan hydrochloride, (3) epinephrine hydrochloride and norepinephrine 
hydrochloride, and (4) mecholyl chloride and atropine sulphate. The last 
two sessions were carried out in another room and due to lack of time, records 
of blood pressure and EKG only were recorded. 
All injections were given via a heparinized intravenous cannula inserted when 
the electrodes were applied. This Heyman-Olafson needle has a rubber dia- 
phragm in it through which all the injections were given; thus it was possible 
to avoid upsetting the patient with the pain of an injection and to give ac- 
curately timed injections. 
The drug tests began with a 5-min. baseline followed by the injection 
of saline and a 5-min. recovery recording. The active drug was then given 
slowly according to a strict schedule over 5 or 6 min., and a recovery recording 
was taken for a 15-min. period. If 2 drugs were given in one session, for example 
epinephrine and norepinephrine, an interval of 30 min. or more, if necessary, 
was allowed for return to baseline of the measures. 
Drug dosage was adjusted to body weight as follows: yohimbine hydro- 
chloride, 0.1 mg./kg./min., for 5 min. ; piperoxan hydrochloride, 0.07 mg./kg./ 
min., for 5 min.; epinephrine hydrochloride, 0.2 pg./kg./min., for 6 min.; 
norepinephrine hydrochloride, 0.2 pg./kg./min., over 6 min.; mecholyl chloride, 
5 pg./kg./min., over 6 min.; and atropine sulphate, 8 pg./kg./min., over 5 min. 
The recording instrument was a model T Offner EEG, and the variables 
The tests were carried out over six recording sessions. 
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recorded were: (1) respiration: abdominal movements recorded by means of 
the change in resistance of a thin rubber tube filled with acetic acid; (2) EKG: 
taken from precordial leads to get records free from movement artifact; (3)  
ballistocardiogram: recorded during a highly damped system capable of a 
frequency response of 10/sec.; (4) skin temperature: taken by a thermistor 
fixed to the back of the fifth finger; (5) skin resistance: using a small alternat- 
ing current to overcome the effects of polarization; and (6) blood pressure: 
recorded every half minute manually using a mercury sphygmomanometer. 
The degree of anxiety or emotional reactivity of each subject was rated 
independently by 6 raters: 2 of them on the ward, 2 during psychological 
testing, and 2 in the polygraph room using a bipolar 8-point scale ranging from 
0 (markedly under reactive) through 3 (normal) to 7 (greatly over reactive). 
Results 
For this analysis, a score for the resting activity of each autonomic variable 
was obtained for each subject by taking the mean value of the 5-min. resting 
baseline. The difference between this score and the mean of a fixed period 
during and after stress or a drug gave us a score for drug or stress responses. 
The sample, for the purposes of comparison, was divided into five groups on 
the basis of psychiatric diagnosis as follows: (1) paranoid schizophrenics, (2) 
all other schizophrenics, (3)  uncertain diagnosis, (4) nonschizophrenics with 
chronic brain syndrome, and (5) all other nonschizophrenics. An analysis of 
variance was carried out on these five groups. 
A comparison of the resting autonomic activity of subjects showed only two 
statistically significant differences: 
(1) The paranoid schizophrenic showed greater respiratory irregularity, 
both in depth and rate, than the others. This was at  the 0.1 per cent level of 
probability. 
(2) All the schizophrenics had a higher skin resistance at the 1 per cent level 
of probability. 
In their response to stress we found no difference in the heart rate, blood 
pressure, or skin temperature change. However all the schizophrenics showed 
a greater fall in skin resistance than the other subjects. At the 0.1 per cent 
level of probability was the difference in respiration rate change during stress 
between the paranoids and the others. 
Only one drug response seemed to differentiate the groups to any degree, 
the schizophrenic patient showing a smaller rise in blood pressure when given 
norepinephrine (p < 0.01). 
A high degree of agreement was found between the six raters on the anxiety 
scale: p < 0.005. There was no significant difference in the anxiety score of 
our groups except for the paranoids, who had a slightly higher mean value. 
Conclusions 
Apart from those mentioned in the results, there seems to be no marked 
difference in the resting level of autonomic activity or its responsiveness to 
stress and drugs in the sample of schizophrenics that we have studied. The 
groups used in this analysis of variance have been similar in mean age and 
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in anxiety level. The subjects have all been hospitalized, off drugs for two 
months prior to testing, on a strict diet, and have been given the test drugs 
intravenously on a dosage-per-weight basis. The differences so often reported 
previously may have been due to one or more of these factors and not to the 
disease process itself. 
However, it is true that although there was no difference in means, the 
variance in some of the measures was found to be much greater among the 
schizophrenics than among the nonschizophrenics. Therefore the next stage 
of our investigation will be, after finding the correlations between the autonomic 
variables and the biochemical, psychological, psychiatric, and social history 
areas of the Research Project, to find new meaningful subgroups within schizo- 
phrenia, using a combination of measures from these areas. 
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